BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27492273)

  • 21. Peripheral Edema, Central Venous Pressure, and Risk of AKI in Critical Illness.
    Chen KP; Cavender S; Lee J; Feng M; Mark RG; Celi LA; Mukamal KJ; Danziger J
    Clin J Am Soc Nephrol; 2016 Apr; 11(4):602-8. PubMed ID: 26787777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden.
    Brusselaers N; Wahlin K; Engstrand L; Lagergren J
    BMJ Open; 2017 Oct; 7(10):e017739. PubMed ID: 29084798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histamine H2-Blocker and Proton Pump Inhibitor Use and the Risk of Pneumonia in Acute Stroke: A Retrospective Analysis on Susceptible Patients.
    Arai N; Nakamizo T; Ihara H; Koide T; Nakamura A; Tabuse M; Miyazaki H
    PLoS One; 2017; 12(1):e0169300. PubMed ID: 28085910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse outcomes of proton pump inhibitors in patients with chronic kidney disease: The CKD-REIN cohort study.
    Liabeuf S; Lambert O; Metzger M; Hamroun A; Laville M; Laville SM; Frimat L; Pecoits-Filho R; Fouque D; Massy ZA; Jacquelinet C; Stengel B;
    Br J Clin Pharmacol; 2021 Jul; 87(7):2967-2976. PubMed ID: 33368448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton pump inhibitors and the risk of acute kidney injury in cancer patients receiving immune checkpoint inhibitors: A Danish population-based cohort study.
    Munch PV; Nørgaard M; Heide-Jørgensen U; Jensen SK; Birn H; Christiansen CF
    Int J Cancer; 2024 Apr; 154(7):1164-1173. PubMed ID: 37983738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of Proton Pump Inhibitors and the Risk of Acute Kidney Injury Among Patients with Rheumatoid Arthritis: Cohort Study.
    Svanström H; Lund M; Melbye M; Pasternak B
    Drug Saf; 2018 Aug; 41(8):817-826. PubMed ID: 29603109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of proton pump inhibitors and concomitant drugs with risk of acute kidney injury: a nested case-control study.
    Ikuta K; Nakagawa S; Momo K; Yonezawa A; Itohara K; Sato Y; Imai S; Nakagawa T; Matsubara K
    BMJ Open; 2021 Feb; 11(2):e041543. PubMed ID: 33589451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evolution of chronic renal impairment and long-term mortality after de novo acute kidney injury in the critically ill; a Swedish multi-centre cohort study.
    Rimes-Stigare C; Frumento P; Bottai M; Mårtensson J; Martling CR; Walther SM; Karlström G; Bell M
    Crit Care; 2015 May; 19(1):221. PubMed ID: 25944032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proton Pump Inhibitor Use, Fatigue, and Health-Related Quality of Life in Kidney Transplant Recipients: Results From the TransplantLines Biobank and Cohort Study.
    Knobbe TJ; Kremer D; Douwes RM; Eisenga MF; Gomes-Neto AW; Annema C; Swarte JC; Klont F; Navis G; Berger SP; Bakker SJL;
    Am J Kidney Dis; 2023 Aug; 82(2):189-201.e1. PubMed ID: 36801431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence and Outcome of Subclinical Acute Kidney Injury Using penKid in Critically Ill Patients.
    Dépret F; Hollinger A; Cariou A; Deye N; Vieillard-Baron A; Fournier MC; Jaber S; Damoisel C; Lu Q; Monnet X; Rennuit I; Darmon M; Leone M; Guidet B; Sonneville R; Montravers P; Pili-Floury S; Lefrant JY; Duranteau J; Laterre PF; Brechot N; Oueslati H; Cholley B; Struck J; Hartmann O; Mebazaa A; Gayat E; Legrand M
    Am J Respir Crit Care Med; 2020 Sep; 202(6):822-829. PubMed ID: 32516543
    [No Abstract]   [Full Text] [Related]  

  • 31. Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD.
    Xie Y; Bowe B; Li T; Xian H; Balasubramanian S; Al-Aly Z
    J Am Soc Nephrol; 2016 Oct; 27(10):3153-3163. PubMed ID: 27080976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proton Pump Inhibitor Use and Magnesium Concentrations in Hemodialysis Patients: A Cross-Sectional Study.
    Nakashima A; Ohkido I; Yokoyama K; Mafune A; Urashima M; Yokoo T
    PLoS One; 2015; 10(11):e0143656. PubMed ID: 26618538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of hyperchloremia on acute kidney injury in critically ill septic patients: a retrospective cohort study.
    Yessayan L; Neyra JA; Canepa-Escaro F; Vasquez-Rios G; Heung M; Yee J;
    BMC Nephrol; 2017 Dec; 18(1):346. PubMed ID: 29197350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proton pump inhibitors and the risk of hospital-acquired acute kidney injury in children.
    Li Y; Xiong M; Yang M; Wang L; Nie S; Liu D; Pi M; Zhang A; Mao J; Liu HP; Xia H; Xu H; Liu Z; Feng S; Zhou W; Liu X; Yang Y; Tao Y; Feng Y; Chen C; Wang M; Zha Y; Feng JH; Li Q; Ge S; Chen J; He Y; Teng S; Hao C; Liu BC; Tang Y; He W; Hou FF; Xu X
    Ann Transl Med; 2020 Nov; 8(21):1438. PubMed ID: 33313183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proton-Pump Inhibitors and Risk of Calcium Pyrophosphate Deposition in a Population-Based Study.
    Liew JW; Peloquin C; Tedeschi SK; Felson DT; Zhang Y; Choi HK; Terkeltaub R; Neogi T
    Arthritis Care Res (Hoboken); 2022 Dec; 74(12):2059-2065. PubMed ID: 35245410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Benefits and risks of stress ulcer prevention with proton pump inhibitors for critical patients: an observational cohort study with 1 972 patients].
    Sun J; Wang B; Cao P; Zhu H; Lu K; Geng P; Tan D
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 May; 31(5):539-544. PubMed ID: 31198136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal Transplant Acute Rejection with Lower Mycophenolate Mofetil Dosing and Proton Pump Inhibitors or Histamine-2 Receptor Antagonists.
    Patel KS; Stephany BR; Barnes JF; Bauer SR; Spinner ML
    Pharmacotherapy; 2017 Dec; 37(12):1507-1515. PubMed ID: 28976570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomarker Predictors of Adverse Acute Kidney Injury Outcomes in Critically Ill Patients: The Dublin Acute Biomarker Group Evaluation Study.
    McMahon BA; Galligan M; Redahan L; Martin T; Meaney E; Cotter EJ; Murphy N; Hannon C; Doran P; Marsh B; Nichol A; Murray PT
    Am J Nephrol; 2019; 50(1):19-28. PubMed ID: 31203271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stress ulcer prophylaxis with proton pump inhibitors or histamine 2 receptor antagonists in critically ill adults - a meta-analysis of randomized controlled trials with trial sequential analysis.
    Zhou X; Fang H; Xu J; Chen P; Hu X; Chen B; Wang H; Hu C; Xu Z
    BMC Gastroenterol; 2019 Nov; 19(1):193. PubMed ID: 31752703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients.
    Barletta JF; Sclar DA
    Crit Care; 2014 Dec; 18(6):714. PubMed ID: 25540023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.